ACTIVE_NOT_RECRUITING

Developing a Culturally Adapted Intervention for Latino Youth Transitioning to Adulthood

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the acceptability, feasibility (e.g., satisfaction, completion rate, barriers to recruitment, treatment fidelity) of the culturally refined Launching! to Adulthood (¡Iniciando! la Adultez) program, to test for a preliminary signal of effect between baseline and post-treatment for the Launching! to Adulthood (¡Iniciando! la Adultez) program and to identify preliminary neural mechanisms of action, including biomarkers of brain structure and connectivity, in terms of treatment response for 15 Latino young adults participating in the ¡Iniciando! therapy program.

Official Title

Developing a Culturally Adapted Intervention for Latino Youth Transitioning to Adulthood

Quick Facts

Study Start:2024-04-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06107972

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * confirmed case of ASD
  2. * a score of \>14 on the Social Communication Questionnaire-Lifetime (SCQ-L110) completed with the mother or father
  3. * meet DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 ASD symptom checklist
  4. * previous diagnosis of ASD from a licensed mental health or medical professional
  5. * speak English
  6. * have a parent willing to participate
  7. * score \>85 on verbal intelligence quotient (IQ) on the Kaufman Brief Intelligence Test (KBIT-2)
  1. * history of a psychotic disorder or current psychotic symptoms
  2. * suicidal ideation with intent or plan
  3. * current alcohol or other substance use disorder rated severe
  4. * concurrent enrollment in another clinical trial for autism spectrum disorder
  5. * expression of unwillingness to complete study procedures
  6. * For fMRI, unable to undergo fMRI scanning due to metallic devices or objects (cardiac pacemaker or neurostimulator, some artificial joints, metal pins, surgical clips, or other implanted metal parts) or claustrophobic to the scanner.

Contacts and Locations

Principal Investigator

Antonio Pagan, PhD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Antonio Pagan, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-04-01
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder